Ledger.Open graph →

SEC Form D · filed October 30, 2024

Sethera Therapeutics, Inc

Offering

$3.0M

Sold

$1.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SALT LAKE CITY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Michael J. Paul · Salt Lake City, UTExec · Director Vahe Bandarian · Salt Lake City, UTExec · Director Karsten Eastman · Salt Lake City, UTExec · Director Cynthia Tsai · Salt Lake City, UTExec · Director Yakov Kogan · Salt Lake City, UTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗